{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalazine",
          "name": "Mesalazine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_sulfasalazine",
          "name": "Sulfasalazine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_tegaserod",
          "name": "Tegaserod"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_probiotics",
          "name": "Probiotics"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_balsalazide",
          "name": "Balsalazide"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_loperamide",
          "name": "Loperamide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_octreotide",
          "name": "Octreotide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_mesalazine",
          "type": "Drug",
          "label": "Mesalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sulfasalazine",
          "type": "Drug",
          "label": "Sulfasalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tegaserod",
          "type": "Drug",
          "label": "Tegaserod",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_balsalazide",
          "type": "Drug",
          "label": "Balsalazide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_octreotide",
          "type": "Drug",
          "label": "Octreotide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_inflammation",
          "type": "Target",
          "label": "Inflammatory Pathway Target",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_regulation",
          "type": "Pathway",
          "label": "Regulation of Inflammatory Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_improvement",
          "type": "Phenotype",
          "label": "Improvement of Gastrointestinal Health",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_mesalazine",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知机制支持对炎症的影响"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于免疫调节的常识"
        },
        {
          "source": "drug_budesonide",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与气道炎症相关的机制"
        },
        {
          "source": "drug_sulfasalazine",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于治疗肠道炎症"
        },
        {
          "source": "drug_tegaserod",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "对肠道运动的调节作用"
        },
        {
          "source": "drug_probiotics",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "促进有益菌群的机制"
        },
        {
          "source": "drug_infliximab",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "免疫抑制相关药物的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对抗体的机制"
        },
        {
          "source": "drug_vedolizumab",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向肠道的机制"
        },
        {
          "source": "drug_balsalazide",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于治疗炎症性肠病"
        },
        {
          "source": "drug_loperamide",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节肠道运动的功能"
        },
        {
          "source": "drug_octreotide",
          "target": "target_inflammation",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "影响肠道激素的机制"
        },
        {
          "source": "target_inflammation",
          "target": "pathway_regulation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "炎症调节通路的关键靶点"
        },
        {
          "source": "pathway_regulation",
          "target": "phenotype_improvement",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "改善肠道健康的潜在机制"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过炎症通路机制改善胃肠健康",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "各药物具备充分到达目标组织的能力（基于常识）"
    ],
    "uncertainties": [
      "不同病状下的具体疗效与安全性尚需进一步研究"
    ],
    "next_focus_for_pi": [
      "考虑瞄准其他相关通路以补充现有机制"
    ]
  }
}